Deep Origin
Deep Origin is a biotechnology company that help's scientists solve disease and extend healthspan by building tools that simplify R&D, simulate biology, and untangle the complexity of life. Streamline computational analysis today. Simulate biology tomorrow.
Leave No Development Candidate Behind 90% of drugs fail in clinical development. Most of that failure happens because preclinical models are poor predictors of what happens in humans. We are building the models that close that gap. Want to run our tools yourself? Explore the platform → 100+ scientists in biology, chemistry & physics $50M + $32M capital raised · ARPA-H contract 2 / 40 partnership slots filled CD73 program · 159 compounds, 30% hit rate Our team has built and partnered at Drug Discovery Partnerships 9 in 10 drugs entering clinical trials never get approved Decades of…
saved by
related reading
- Convoke | Biopharma's Operating Systemconvoke.bio
- Manifold Bio | Tissue-targeted medicines, designed in vivomanifold.bio
- Gap Mapgap-map.org
- OCTO - Noetiknoetik.ai
- Reimagining Drug Discovery Process with AI - Isomorphic Labsisomorphiclabs.com
- On AI Infrastructure in Biology - by Elliot Hershbergcenturyofbio.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- What will it take for AI to change drug discovery?writingruxandrabio.com
- Drug Discovery Has No Magic Wandsa16z.news
- AI After Drug Developmentasteriskmag.substack.com
- Models of Lifepress.asimov.com
- How unfair is the coin?ankitg.me